MicroRNA-155 Plays Selective Cell-Intrinsic Roles in Brain-Infiltrating Immune Cell Populations during

Jacob W Thompson1, Ruozhen Hu1, Thomas B Huffaker1

  • 1Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.

Insights

MicroRNA-155 (miR-155) drives multiple sclerosis (MS) severity. Conditional knockout in T cells and dendritic cells reduced experimental autoimmune encephalomyelitis (EAE) in mice, highlighting cell-specific therapeutic targets.

Area of Science:

  • Immunology
  • Neuroscience
  • Genetics

Background:

  • MicroRNA-155 (miR-155) is a proinflammatory microRNA implicated in multiple sclerosis (MS).
  • Global knockout of miR-155 in mice confers resistance to experimental autoimmune encephalomyelitis (EAE), a mouse model of MS.
  • The cell-intrinsic roles of miR-155 in distinct immune cell populations during EAE remain undetermined.

Purpose of the Study:

  • To investigate the cell-specific roles of miR-155 in immune cells during the development of EAE.
  • To determine the impact of miR-155 deletion in T cells, macrophages, and dendritic cells (DCs) on EAE pathogenesis.
  • To identify specific immune cell types where miR-155 plays a critical role in MS.

Main Methods:

  • Utilized single-cell RNA sequencing to analyze immune cell populations in global miR-155 knockout (KO) mice.
  • Employed cell-specific conditional miR-155 KO mouse models (CD4 Cre for T cells, CD11c Cre for DCs, LysM Cre for macrophages).
  • Assessed disease severity and CNS-infiltrating Th17 T cell levels in various conditional KO models during EAE induction.

Main Results:

  • Global miR-155 KO mice showed reduced T cells, macrophages, and DCs at day 21 post-EAE induction.
  • Conditional deletion of miR-155 in T cells significantly reduced EAE severity, mirroring global KO effects.
  • Deletion of miR-155 in DCs also led to a significant reduction in EAE, with decreased Th17 T cell infiltration.
  • miR-155 deletion in macrophages did not affect EAE severity, despite its high expression in these cells during EAE.

Conclusions:

  • miR-155 plays distinct, cell-type-dependent roles in the pathogenesis of EAE.
  • T cells and dendritic cells are key immune cell types where miR-155 contributes to MS pathogenesis.
  • Targeting miR-155 in specific immune cells, particularly T cells and DCs, represents a promising therapeutic strategy for MS.